Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient is either receiving high blood pressure monotherapy or no treatment
Patient will have reached the legal age by the time enter the study
Patients diagnosed with mild to moderate essential high blood pressure or high blood pressure with other conditions such as diabetes or cardiovascular diseases and are taking high blood pressure medication (exclude diuretic), but did not meet treatment goal
You may not be if
Patient with high levels of uric acid in the blood who has received medications for uric acid in the urine within 3 months prior to enrollment
Patients who are hypersensitive to any component of the study medication
Patients who are hypersensitive to other sulfonamide-derived drugs
Patients with anuria (hyzaar(R) is not recommended for patients with hepatic impairment or severe renal impairment, creatinine clearance \</= 30 ml/min)
Unstable diabetes (hba1c \> 8%), or a change in diabetes medication during study treatment. patients with stable diabetes may enter the study.
Clareo Health | Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)
